Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Blood (2022) 139 (12): 1908–1919.

https://doi.org/10.1182/blood.2021013290

Published: 2022

Includes: Supplemental data

Journal Articles

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Neeraj Saini, David Marin, Celina Ledesma, Ruby Delgado, Gabriela Rondon, Uday R. Popat, Qaiser Bashir, Chitra M. Hosing, Yago Nieto, Amin M. Alousi, Muzaffar H. Qazilbash, Stefan Ciurea, Elizabeth Shpall, Issa Khouri, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Richard E. Champlin, Partow Kebriaei

Blood (2020) 136 (15): 1786–1789.

https://doi.org/10.1182/blood.2019004685

Published: 2020

Includes: Supplemental data

Journal Articles

Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment

V. Lokesh Battula, Ye Chen, Maria da Graca Cabreira, Vivian Ruvolo, Zhiqiang Wang, Wencai Ma, Sergej Konoplev, Elizabeth Shpall, Karen Lyons, Dirk Strunk, Carlos Bueso-Ramos, Richard Eric Davis, Marina Konopleva, Michael Andreeff

Blood (2013) 122 (3): 357–366.

https://doi.org/10.1182/blood-2012-06-437988

Published: 2013

Includes: Supplemental data

Journal Articles

p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α–mediated down-regulation of CXCL12

Kensuke Kojima, Teresa McQueen, Ye Chen, Rodrigo Jacamo, Marina Konopleva, Naoki Shinojima, Elizabeth Shpall, Xuelin Huang, Michael Andreeff

Blood (2011) 118 (16): 4431–4439.

https://doi.org/10.1182/blood-2011-02-334136

Published: 2011

Includes: Supplemental data

Journal Articles

Targeting Chronic Lymphocytic Leukemia with Cord Blood NK Cells In NSG Model

Dongxia Xing, William Decker, PHD, Sufang Li, Simon Robinson, PhD, Nina Shah, MD, Hong Yang, PHD, Richard E. Champlin, MD, Simrit Parmar, M.D., John G. Gribben, MD, DSc, Catherine M Bollard, MD, Elizabeth Shpall

Blood (2010) 116 (21): 2453.

https://doi.org/10.1182/blood.V116.21.2453.2453

Published: 2010

Journal Articles

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Non-Toxic Preparative Regimen for Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Lymphoid Malignancies.

Partow Kebriaei, MD, Timothy Madden, BS, PHARMD, Reza Kazerooni, RPH, Elizabeth Shpall, MD, Xuemei Wang, MS, Peter Thall, MD, Chitra Hosing, MD, Muzaffar Qazilbash, MD, Uday Popat, MD, Celina Ledesma, BS, Issa Khouri, MD, Richard Champlin, MD, Roy Jones, MD, Borje S. Andersson, MD

Blood (2009) 114 (22): 3415.

https://doi.org/10.1182/blood.V114.22.3415.3415

Published: 2009

Journal Articles

Addition of Umbilical Cord Blood (UCB) Unit to Reduced Intensity Conditioning (RIC) Regimen to Augment Graft Versus Tumor (GVT) in Patients (pts) with Advanced Hematologic Malignancies

Partow Kebriaei, MD, Sergio Giralt, MD, Dan Jones, MD, PhD, Karla Gutierrez, MPH, BS, Marcos De Lima, MD, Martin Korbling, MD, Issa F. Khouri, MD, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Amin Alousi, MD, Stefan O Ciurea, MD, Laurence Cooper, MD, PhD, Elizabeth Shpall, MD, Richard Champlin, MD

Blood (2008) 112 (11): 3297.

https://doi.org/10.1182/blood.V112.11.3297.3297

Published: 2008

Journal Articles

Reduced Intensity Conditioning (RIC) Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Leandro de Padua Silva, Rima M. Saliba, Sergio Giralt, Marcos De Lima, Chitra Hosing, Issa F Khouri, Uday Popat, Muzaffar Qazilbash, Elizabeth Shpall, Deborah A. Thomas, MD, Hagop Kantarjian, Richard Champlin, Partow Kebriaei

Blood (2008) 112 (11): 4326.

https://doi.org/10.1182/blood.V112.11.4326.4326

Published: 2008

Journal Articles

Donor-Recipient Mismatches in MHC Class I Chain-Related Gene a (MICA) in Unrelated Donor (UD) Transplantation

Marcos De Lima, Morgani Rodrigues, Pedro Cano, Peter Stastny, Ping Liu, Wei Wei, Susana Pesoa, Poliana Patah, Elizabeth Shpall, Sergio Giralt, Gabriela Rondon, Martin Korbling, Leandro De Padua Silva, Richard Champlin, Marcelo Fernandez-Vina

Blood (2008) 112 (11): 58.

https://doi.org/10.1182/blood.V112.11.58.58

Published: 2008

Journal Articles

Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study.

Marcos De Lima, Leandro de Padua Silva, Sergio Giralt, Krishna Komanduri, Borje S. Andersson, Chitra Hosing, Muzaffar Qazilbash, Elizabeth Shpall, Peter Thall, Weiqing Zhang, Gloria McCormick, Xuemei Wang, Uday Popat, Andres Soriano, Amin Alousi, Richard Champlin, Guillermo Garcia-Manero

Blood (2008) 112 (11): 1134.

https://doi.org/10.1182/blood.V112.11.1134.1134

Published: 2008

Journal Articles

Double Cord Blood Transplantation (CBT) with and without Ex-Vivo Expansion (EXP): A Randomized, Controlled Study

Blood (2008) 112 (11): 154.

https://doi.org/10.1182/blood.V112.11.154.154

Published: 2008

Journal Articles

Pre Transplant Values of C Reactive Protein (CRP) and Brain Natriuretic Peptide (BNP) as Predictors of Transplant Outcomes in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes (AML/MDS) Undergoing Allogeneic Stem Cell Transplantation (AlloSCT).

Blood (2007) 110 (11): 1984.

https://doi.org/10.1182/blood.V110.11.1984.1984

Published: 2007

Journal Articles

Efficacy of Azacytidine (5-AC) Given as Maintenance or Salvage Therapy for Patients (pts) with Acute Leukemia Post Allogeneic Stem Cell Transplantation (HSCT).

Elias Jabbour, MD, Sergio Giralt, MD, Hagop Kantarjian, MD, Guillermo Garcia-Manero, MD, Elizabeth Shpall, MD, Patrow Kebriaei, MD, Leandro de Padua, MD, Richard Champlin, MD, Marcos de Lima, MD

Blood (2007) 110 (11): 3013.

https://doi.org/10.1182/blood.V110.11.3013.3013

Published: 2007

Journal Articles

Identifying NK-Cell Donors for Cell Therapy Based on Functional Phenotype.

Lenka Hurton, MS, R. Iram Siddik, B.S., Harjeet Singh, Ph.D., Simon Olivares, M.S, Brian Rabinovich, Ph.D., William Hildebrand, Ph.D., Dean Lee, M.D., Ph.D., Richard Champlin, M.D., Elizabeth Shpall, M.D., Marcelo Fernandez-Vina, Ph.D., Laurence Cooper, M.D., Ph.D.

Blood (2007) 110 (11): 3271.

https://doi.org/10.1182/blood.V110.11.3271.3271

Published: 2007

Journal Articles

Nonmyeloablative Allogeneic Transplantation in the Imatinib Era: Three Chances To Achieve Molecular Remission in CML.

Richard E. Champlin, MD, Sergio Giralt, MD, Elizabeth Shpall, MD, Partow Kebriaei, MD, Paolo Anderlini, MD, Muzaffar Qazilbash, MD, John McMannis, PhD, Gloria McCormick, RN, Tobi Fisher, PA, Marcos de Lima, MD, Gabriela Rondon, MD

Blood (2007) 110 (11): 1028.

https://doi.org/10.1182/blood.V110.11.1028.1028

Published: 2007

Journal Articles

Are 2 cords better than 1?

Elizabeth Shpall, Marcos de Lima, Roy Jones, Richard Champlin

Blood (2007) 110 (8): 2789–2790.

https://doi.org/10.1182/blood-2007-07-097691

Published: 2007

Journal Articles

Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells

Siqing Wang, Sungyoul Hong, Jing Yang, Jianfei Qian, Xiang Zhang, Elizabeth Shpall, Larry W. Kwak, Qing Yi

Blood (2006) 108 (13): 4071–4077.

https://doi.org/10.1182/blood-2006-04-016980

Published: 2006

Journal Articles

Induction of Polyclonal T-Cell Responses Against Cutaneous T-Cell Lymphomas by Autologous Dendritic Cells Transfected with Amplified Tumor RNA.

Xiao Ni, MD, PhD, Heather Richmond, B.S., Elizabeth Shpall, M.D., Madeleine Duvic, M.D.

Blood (2006) 108 (11): 5189.

https://doi.org/10.1182/blood.V108.11.5189.5189

Published: 2006

Journal Articles

Umbilical Cord Blood Cells Express mRNA for Neuronal Genes MAP2 and NEFL.

Martin Korbling, MD, Wei Zhang, PhD, David Cogdell, PhD, James Reuben, MD, Hui Gao, PhD, Dongxia Xing, PhD, Ruth Katz, MD, Kawah Chan, MD, Elizabeth Shpall, MD

Blood (2006) 108 (11): 5154.

https://doi.org/10.1182/blood.V108.11.5154.5154

Published: 2006

Journal Articles

Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patient’s Monocyte-Derived Dendritic Cells by Inhibiting p38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in the Progenitor Cells.

Qing Yi, MD, PhD, Siqing Wang, MD, Sungyoul Hong, PhD, Jing Yang, PhD, Jianfei Qian, PhD, Xiang Zhang, MS, Elizabeth Shpall, MD, Larry W. Kwak, MD, PhD

Blood (2006) 108 (11): 3701.

https://doi.org/10.1182/blood.V108.11.3701.3701

Published: 2006

NARROW

Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment

p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α–mediated down-regulation of CXCL12

Targeting Chronic Lymphocytic Leukemia with Cord Blood NK Cells In NSG Model

Intravenous Busulfan Plus Melphalan Is a Highly Effective, Non-Toxic Preparative Regimen for Autologous Stem Cell Transplantation (ASCT) in Patients with Advanced Lymphoid Malignancies.

Addition of Umbilical Cord Blood (UCB) Unit to Reduced Intensity Conditioning (RIC) Regimen to Augment Graft Versus Tumor (GVT) in Patients (pts) with Advanced Hematologic Malignancies

Reduced Intensity Conditioning (RIC) Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Donor-Recipient Mismatches in MHC Class I Chain-Related Gene a (MICA) in Unrelated Donor (UD) Transplantation

Maintenance Therapy with Low-Dose Azacitidine (AZA) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Relapsed or Refractory AML or MDS: A Dose and Schedule Finding Study.

Double Cord Blood Transplantation (CBT) with and without Ex-Vivo Expansion (EXP): A Randomized, Controlled Study

Pre Transplant Values of C Reactive Protein (CRP) and Brain Natriuretic Peptide (BNP) as Predictors of Transplant Outcomes in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes (AML/MDS) Undergoing Allogeneic Stem Cell Transplantation (AlloSCT).

Efficacy of Azacytidine (5-AC) Given as Maintenance or Salvage Therapy for Patients (pts) with Acute Leukemia Post Allogeneic Stem Cell Transplantation (HSCT).

Identifying NK-Cell Donors for Cell Therapy Based on Functional Phenotype.

Nonmyeloablative Allogeneic Transplantation in the Imatinib Era: Three Chances To Achieve Molecular Remission in CML.

Are 2 cords better than 1?

Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells

Induction of Polyclonal T-Cell Responses Against Cutaneous T-Cell Lymphomas by Autologous Dendritic Cells Transfected with Amplified Tumor RNA.

Umbilical Cord Blood Cells Express mRNA for Neuronal Genes MAP2 and NEFL.

Optimizing Immunotherapy in Multiple Myeloma: Restoring the Function of Patient’s Monocyte-Derived Dendritic Cells by Inhibiting p38 or Activating MEK/ERK MAPK and Neutralizing Interleukin-6 in the Progenitor Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only